全文获取类型
收费全文 | 1509篇 |
免费 | 145篇 |
国内免费 | 1篇 |
专业分类
1655篇 |
出版年
2022年 | 15篇 |
2021年 | 32篇 |
2020年 | 22篇 |
2019年 | 17篇 |
2018年 | 23篇 |
2017年 | 19篇 |
2016年 | 44篇 |
2015年 | 77篇 |
2014年 | 61篇 |
2013年 | 57篇 |
2012年 | 102篇 |
2011年 | 93篇 |
2010年 | 68篇 |
2009年 | 46篇 |
2008年 | 70篇 |
2007年 | 76篇 |
2006年 | 49篇 |
2005年 | 69篇 |
2004年 | 46篇 |
2003年 | 49篇 |
2002年 | 36篇 |
2001年 | 41篇 |
2000年 | 32篇 |
1999年 | 28篇 |
1998年 | 14篇 |
1997年 | 17篇 |
1996年 | 19篇 |
1995年 | 11篇 |
1994年 | 17篇 |
1993年 | 16篇 |
1992年 | 18篇 |
1991年 | 20篇 |
1990年 | 16篇 |
1989年 | 16篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 17篇 |
1985年 | 24篇 |
1984年 | 19篇 |
1983年 | 15篇 |
1982年 | 13篇 |
1981年 | 9篇 |
1980年 | 12篇 |
1979年 | 12篇 |
1978年 | 14篇 |
1977年 | 9篇 |
1975年 | 9篇 |
1971年 | 13篇 |
1969年 | 9篇 |
1968年 | 8篇 |
排序方式: 共有1655条查询结果,搜索用时 8 毫秒
191.
Mugabe C Matsui Y So AI Gleave ME Heller M Zeisser-Labouèbe M Heller L Chafeeva I Brooks DE Burt HM 《Biomacromolecules》2011,12(4):949-960
The objective of this study was to evaluate the tolerability, to establish a dosing regimen, and to evaluate the efficacy of intravesical docetaxel (DTX) formulations in a mouse model of bladder cancer. DTX in commercial formulation (Taxotere, DTX in Tween 80) or loaded in hyperbranched polyglycerols (HPGs) was evaluated. The synthesis and characterization of HPGs with hydrophobic cores and derivatized with methoxy poly(ethylene glycol) in the shell and further functionalized with amine groups (HPG-C(8/10)-MePEG and HPG-C(8/10)-MePEG-NH(2)) is described. Intravesical DTX in either commercial or HPGs formulations (up to 1.0 mg/mL) was instilled in mice with orthotopic bladder cancer xenografts and was well tolerated with no apparent signs of local or systemic toxicities. Furthermore, a single dose of intravesical DTX (0.5 mg/mL) loaded in HPGs was significantly more effective in reducing the tumor growth in an orthotopic model of bladder cancer than the commercial formulation of Taxotere. In addition, DTX-loaded HPG-C(8/10)-MePEG-NH(2) was found to be more effective at lower instillation dose than DTX (0.2 mg/mL)-loaded HPG-C(8/10)-MePEG. Overall, our data show promising antitumor efficacy and safety in a recently validated orthotopic model of bladder cancer. Further research is warranted to evaluate its safety and efficacy in early phase clinical trials in patients refractory to standard intravesical therapy. 相似文献
192.
Neale BM Rivas MA Voight BF Altshuler D Devlin B Orho-Melander M Kathiresan S Purcell SM Roeder K Daly MJ 《PLoS genetics》2011,7(3):e1001322
Technological advances make it possible to use high-throughput sequencing as a primary discovery tool of medical genetics, specifically for assaying rare variation. Still this approach faces the analytic challenge that the influence of very rare variants can only be evaluated effectively as a group. A further complication is that any given rare variant could have no effect, could increase risk, or could be protective. We propose here the C-alpha test statistic as a novel approach for testing for the presence of this mixture of effects across a set of rare variants. Unlike existing burden tests, C-alpha, by testing the variance rather than the mean, maintains consistent power when the target set contains both risk and protective variants. Through simulations and analysis of case/control data, we demonstrate good power relative to existing methods that assess the burden of rare variants in individuals. 相似文献
193.
RNase HI from the hyperthermophile Sulfolobus tokodaii (Sto-RNase HI) is stabilized by its C-terminal residues. In this work, the stabilization effect of the Sto-RNase HI C-terminal residues was investigated in detail by thermodynamic measurements of the stability of variants lacking the disulfide bond (C58/145A), or the six C-terminal residues (ΔC6) and by structural analysis of ΔC6. The results showed that the C-terminal does not affect overall structure and stabilization is caused by local interactions of the C-terminal, suggesting that the C-terminal residues could be used as a "stabilization tag." The Sto-RNase HI C-terminal residues (-IGCIILT) were introduced as a tag on three proteins. Each chimeric protein was more stable than its wild-type protein. These results suggested the possibility of a simple stabilization technique using a stabilization tag such as Sto-RNase HI C-terminal residues. 相似文献
194.
Ahmed SB Ronksley PE Hemmelgarn BR Tsai WH Manns BJ Tonelli M Klarenbach SW Chin R Clement FM Hanly PJ 《PloS one》2011,6(4):e19029
Background
Although obstructive sleep apnea (OSA) is more common in patients with kidney disease, whether nocturnal hypoxia affects kidney function is unknown.Methods
We studied all adult subjects referred for diagnostic testing of sleep apnea between July 2005 and December 31 2007 who had serial measurement of their kidney function. Nocturnal hypoxia was defined as oxygen saturation (SaO2) below 90% for ≥12% of the nocturnal monitoring time. The primary outcome, accelerated loss of kidney function, was defined as a decline in estimated glomerular filtration rate (eGFR) ≥4 ml/min/1.73 m2 per year.Results
858 participants were included and followed for a mean study period of 2.1 years. Overall 374 (44%) had nocturnal hypoxia, and 49 (5.7%) had accelerated loss of kidney function. Compared to controls without hypoxia, patients with nocturnal hypoxia had a significant increase in the adjusted risk of accelerated kidney function loss (odds ratio (OR) 2.89, 95% confidence interval [CI] 1.25, 6.67).Conclusion
Nocturnal hypoxia was independently associated with an increased risk of accelerated kidney function loss. Further studies are required to determine whether treatment and correction of nocturnal hypoxia reduces loss of kidney function. 相似文献195.
Zeh C Amornkul PN Inzaule S Ondoa P Oyaro B Mwaengo DM Vandenhoudt H Gichangi A Williamson J Thomas T Decock KM Hart C Nkengasong J Laserson K 《PloS one》2011,6(6):e21040
Background
There is need for locally-derived age-specific clinical laboratory reference ranges of healthy Africans in sub-Saharan Africa. Reference values from North American and European populations are being used for African subjects despite previous studies showing significant differences. Our aim was to establish clinical laboratory reference values for African adolescents and young adults that can be used in clinical trials and for patient management.Methods and Findings
A panel of 298, HIV-seronegative individuals aged 13–34 years was randomly selected from participants in two population-based cross-sectional surveys assessing HIV prevalence and other sexually transmitted infections in western Kenya. The adolescent (<18 years)-to-adults (≥18 years) ratio and the male-to-female ratio was 1∶1. Median and 95% reference ranges were calculated for immunohematological and biochemistry values. Compared with U.S-derived reference ranges, we detected lower hemoglobin (HB), hematocrit (HCT), red blood cells (RBC), mean corpuscular volume (MCV), neutrophil, glucose, and blood urea nitrogen values but elevated eosinophil and total bilirubin values. Significant gender variation was observed in hematological parameters in addition to T-bilirubin and creatinine indices in all age groups, AST in the younger and neutrophil, platelet and CD4 indices among the older age group. Age variation was also observed, mainly in hematological parameters among males. Applying U.S. NIH Division of AIDS (DAIDS) toxicity grading to our results, 40% of otherwise healthy study participants were classified as having an abnormal laboratory parameter (grade 1–4) which would exclude them from participating in clinical trials.Conclusion
Hematological and biochemistry reference values from African population differ from those derived from a North American population, showing the need to develop region-specific reference values. Our data also show variations in hematological indices between adolescent and adult males which should be considered when developing reference ranges. This study provides the first locally-derived clinical laboratory reference ranges for adolescents and young adults in western Kenya. 相似文献196.
197.
198.
199.
200.